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Abstract
Objective To analyse bilateral differences in the cross-
sectional area of the internal mammary artery (IMA) and vein
(IMV) in breast cancer patients compared to healthy controls.
Materials and methods On 135 breast MRIs the cross-
sectional areas of the IMA and IMV were measured on the
left and right side in the second and third intercostal space
(ICS) by two independent readers. Differences were ana-
lysed using a linear mixed model.
Results In the healthy control group (n = 91) no significant
differences between the cross-sectional areas of the IMA and
IMV were observed. Both readers reported a mean adjusted
difference of 0.12 mm2 (p = 0.298) and 0.21 mm2 (p = 0.058)
for the IMA in the second ICS. In the malignancy group
(n = 44) the cross-sectional area was significantly larger on
the malignancy side compared to the contralateral side. The
largest difference in the IMAwas measured in the second ICS
with a mean adjusted difference for reader 1 of 1.37 mm2
(p < 0.001) and for reader 2 of 0.81 mm2 (p = 0.003).
Conclusions The vascular cross-sectional area of internal
mammary vessels was significantly different on the side
with breast cancer compared to the contralateral side. This
difference was not observed in healthy controls.
Main messages
• MRI has become an important imaging modality in the
diagnostic workup of breast cancer.
• In healthy persons no significant difference in the size of
the left and right IMA is observed.
• A significant enlargement of the IMA on the malignant
side occurs in most patients.
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Introduction
Magnetic resonance imaging (MRI) has become an important
imaging modality in the diagnostic workup of breast cancer
patients. Breast MRI is the most accurate method for detecting
breast cancer, with a reported sensitivity and specificity of
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90% [95% confidence interval (CI) 88–92%] and 72% (95%
CI 67–77 %), respectively [1]. Breast MRI could be indicated
for screening in high-risk patients (i.e. BRCA mutations), in
cases where multiple tumour foci are suspected, and for eval-
uation of the effects of neoadjuvant chemotherapy [2, 3]. On
MRI morphology, enhancement characteristics and signal in-
tensity time curves are mostly used to differentiate between
benign andmalignant lesions. However, breastMRI specificity
is only moderate, resulting in many false-positive findings [1].
Several studies have demonstrated a positive correlation be-
tween breast cancer and increased breast vascularity [4–8].
Nevertheless, these studies were not all able to improve the
specificity of the MRI by using this information. However, a
study from Schmitz et al. showed an increased specificity from
74 % to 87 % when adding vascular maps as a parameter,
without affecting the sensitivity [9].
With respect to breast MRI, most researchers use one of
the two following methods to assess changes in vascularity
in the presence of malignancy. The first method focuses on
prominent vessels leading to an enhanced lesion, the so-
called adjacent vessel sign (AVS) [10]. The second method
consists of imaging the vascularity of the whole breast on
both sides with contrast-enhanced MRI [8]. However, both
techniques have shortcomings.
In healthy persons the breast is mainly perfused by the
internal mammary artery (IMA) [11]. It is a paired artery, one
running on the left side of the sternum and one on the right side.
We hypothesised that if amalignant lesion is present the cross-
sectional area of the IMA and/or internal mammary veins (IMV)
on the side of the lesion is increased compared to the healthy side.
Measuring and comparing the left and right IMA and
IMV could only be useful if the cross-sectional areas of
these vessels in a healthy person without breast malignancy
are similar. However, a cadaver study of the IMA and IMV
with a small population showed that the cross-sectional area
of the right IMA was significantly larger than the left in
healthy persons [12]. Confounders that might be responsible
for this difference could probably be detected, such as
anatomical variation, breast density and breast volume.
The aim of this study was to investigate whether a significant
difference exists between the cross-sectional area of IMA and
IMV between the healthy and the malignant side in unilateral
breast cancer patients. We further investigated whether this dif-
ference is absent in healthy persons and whether the cross-
sectional areameasurements are reproducible for various readers.
Materials and methods
Patients
In this retrospective analysis, 294 consecutive breast MRI
exams were performed in 289 patients during a 3-month
period. No power calculation was performed because of the
proof of principle concept of this study. Exclusion criteria
were history of breast-conserving surgery, mastectomy, free-
flap oncoplastic reconstruction, neoadjuvant chemotherapy
and patients with bilateral breast cancer. In case of multiple
MRI exams of one patient, only the first MRI was included. A
single radiologist independently considered all MRI exams for
inclusion. A total of 125 MRI exams were excluded (Table 1).
During image analysis an additional 34 MRI exams were
excluded because the internal mammary artery and vein(s)
were inadequately depicted, resulting in the inclusion of 135
patients. Patients were divided into two groups: a healthy
control and a malignancy group. Patients with invasive breast
cancer or carcinoma in situ were considered as malignant.
Imaging
MRI exams were performed at 1.5 T (Philips Healthcare, Best,
The Netherlands) using a dedicated bilateral 16-channel breast
coil. Breast MRI was performed either before or after tissue
sampling. Timing and techniques used during tissue sampling
were registered. For this study, a non-enhanced 3D T2W TSE
sequence was used, which is part of our standard MRI mam-
mography protocol. The following scan parameters were used:
Field of view 208 × 369, TR 2,000 ms, TE 205 ms, flip angle
90° in transverse plane and reconstructed voxel size 0.96 ×
0.96 × 1.00 mm. This non-enhanced sequence was used be-
cause the internal mammary vessels were best visualised on
this sequence, compared to the contrast-enhanced subtraction
images, which are standard in our breast MRI protocol as well.
Additionally, the readers were generally blinded to the pres-
ence of breast tumours by choosing this sequence because
most cancers cannot be accurately identified on non-
enhanced T2-weighted images because of the large overlap
of T2 relaxation times in benign and malignant breast lesions.
It is well known that contrast enhancement is mandatory for
accurate identification of breast cancers [13]. Coronal planes
were reconstructed. Digital mammographies were used for the
assessment of the breast density. All digital mammographies
Table 1 Reason for exclusion of patients
Patient exclusion reason n %
Breast-conservating therapy in history 61 38
Mastectomy in history 18 11
Free-flap oncoplastic reconstruction 17 11
Neoadjuvant chemotherapy 4 3
Bilateral breast cancer 1 1
Benign breast surgery in history 5 3
Other 19 12
Insufficient MRI quality 34 21
Total 159 100
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were acquired on a dedicated mammography system (Senop-
graphe Essential, GE Healthcare, Waukesha, WI, USA).
Histopathology
Pathological data of all included patients were gathered. All
biopsies and operation specimens were classified by a pa-
thologist according to the World Health Organisation guide-
lines. For this study, size and type of malignancy were
gathered in the database.
Image analysis
All MRIs were assessed for regular patient care according to
the BI-RADS lexicon. Additional analyses were indepen-
dently performed by two readers using a dedicated viewing
work station. Both readers had similar clinical experience,
were not trained in reporting breast MRI and were blinded
for all clinical data, including the breast MRI results. First,
images were reconstructed in a coronal imaging plane by
multiplanar reconstruction (Fig. 2a). Using this view the
anatomical classification of the internal mammary artery
and vein(s) was evaluated. It is a paired artery, one running
on the left side of the sternum and one on its right side. In
combination with the common running vein(s) several ana-
tomical variations are known. The four most frequent var-
iations were standardised by Schwabegger, the so-called
Schwabegger classification [14] (Fig. 1). Discrepancies on
anatomical classification were resolved by consulting a third
reader, an expert reader of breast MRIs. Identification of the
IMA and IMV was ensured by following the vessels to their
origins. Afterwards transverse images were used. The ma-
nubrium (Fig. 2b) was used as a landmark for identifying the
second rib. The cross-sectional area of the IMA and IMV(s)
was measured in the second and third intercostal space (ICS)
below the upper edge of the rib and a so-called “free hand
region of interest” was drawn. Intraobserver reproducibility
was assessed by one reader. This reader reassessed the
cross-sectional area of the IMA in the second ICS in all
patients with an appropriate time interval between these
analyses of more than 6 months using a different coding
for the separate cases to avoid recall bias. Breast density was
determined on digital mammography using a semi-
automatic threshold technique [15].
Statistical analysis
The interobserver agreement of anatomical variations was
analysed using the unweighted Cohen’s kappa coefficient.
The intraobserver reproducibility was assessed by calculating
the intraclass correlation coefficient (ICC) using the one-way
randommodel. A linear mixed-model analysis was performed
to investigate differences between the cross-sectional area of
the left and right internal mammary vessels, accounting for the
correlation between both cross-sectional area measurements
within the same patient. In addition, with the use of this linear
mixed model, also a possible correlation between the cross-
sectional area of the IMA/IMVand anatomical variation, age,
breast volume or breast density was tested. In a linear mixed
model, the responses from a subject are thought to be the sum
(linear) of so-called fixed and random effects. If an effect
affects the population mean, it is fixed. If an effect is associ-
ated with a sampling procedure, it is random.With the use of a
linear-mixed model, the effects of these fixed and random
effects are estimated in one model and adjustments can be
made. Therefore it provides a useful approach for analysing a
wide variety of data. The Statistical Package for the Social
Sciences (SPSS), version 18 (Chicago, Illinois) was used for
data collection and statistical analysis. P-values < 0.05 were
considered statistically significant.
Results
The median age of the control group (n = 91) was 50 years
(range 19–79) compared to a median of 59 years (range 16–
86) in the malignancy group (n = 44). The median diameter
of all invasive tumours in the malignancy group was
2.20 cm (range 0.45–5.50 cm). Table 2 shows the variation
in malignancies. In the control group tissue sampling of
suspicious lesions was performed in 17 patients (9 core
biopsies, 3 stereotactic biopsies, 4 MRI-guided biopsies
Fig. 1 Four internal mammary
artery and vein patterns as
described by Schwabegger.
Type 1 (a). Type 2 (b). Type 3
(c). Type 4 (d). From: Arnez et
al., Br J Plast Surg. 1995
Dec;48(8):540–5
Insights Imaging (2013) 4:177–184 179
and 1 fine-needle aspiration cytology). In six patients biopsy
was performed before breast MRI and in 11 patients after-
wards. Tissue sampling was performed in all 44 patients in
the malignant group [37 core biopsies, 5 stereotactic biop-
sies (vacuum assisted) and 2 MRI-guided biopsies]. In 35
patients breast MRI was performed after tissue sampling and
in 9 patients before tissue sampling.
Classification of the anatomy of the IMA and IMVaccord-
ing to Schwabegger resulted in an incidence of type 1, 2, 3 and
4 of 16 (5.9 %), 209 (77.4 %), 2 (0.7 %) and 35 (13.0 %)
respectively. Another eight (3.0 %) anatomical variations
could not be described with the Schwabegger classification
[14]. For the left side, the readers’ interobserver agreement
showed a kappa value of 0.716; for the right side the kappa
value was 0.728, both indicating good agreement.
Results of cross-sectional area measurements of the IMA
and IMV underneath the second and third rib are summar-
ised in Tables 3 (control group) and 4 (malignancy group)
for both readers.
Analysis of the cross-sectional area measurements per-
formed by reader 1 of the IMA and IMV in the control group
showed no significant differences between both sides in either
the second or third ICS. The measured mean cross-sectional
area of the IMA in the second ICS was 4.26 mm2 on the left
side (range 1.99–12.41) and 4.36 mm2 on the right side (2.08–
11.06). The adjusted difference between the left and right IMA
as result of the linear mixed model analysis was only
0.12 mm2 (p = 0.298). The cross-sectional area measurement
of the IMA in the second ICS was 4.32 mm2 on the left side
(range 1.02–7.93) and 4.54mm2 on the right side (range 2.15–
8.31) measured by reader 2. Also all other measurements of
reader 2 confirmed the results of reader 1; no significant
differences existed between the two sides.
In the malignancy group, the results of reader 1 showed a
significant difference in the cross-sectional area of the IMA
and IMV in the second as well as in the third ICS between
the healthy and malignant side (see Fig. 3 for an example).
The measured mean cross-sectional area of the IMA in the
second ICS was 4.63 mm2 on the healthy side (range 2.01–
13.22) and 5.94 mm2 on the malignant side (2.06–13.53).
For the IMA in the second ICS, the largest enlargement of
an internal mammary vessel was reported with a mean
adjusted difference for reader 1 of 1.37 mm2 (p < 0.001).
The results of reader 2 in the malignancy group showed
similar results as reader 1; a significant difference existed in
the second as well as in the third ICS between the healthy
and malignant side, and the largest enlargement was seen in
the IMA in the second ICS (0.81 mm2, p = 0.003) too. The
reproducibility of the cross-sectional area measurements of
the IMA in the second ICS by reader 1 proved to be good in
all patients (ICC 0.79, 95 % CI 0.65–0.88).
The semi-automatic threshold technique to estimate the
breast density of patients showed a median breast density of
24%with a standard deviation of 16%. Together with age and
anatomical variation, the mixed model analysis showed no
significant correlation (all p values > 0.141 for both readers)
for left-right differences of the vascular cross-sectional areas,
in both the control and malignancy group.
Fig. 2 An example of recognising the Schwabegger classification and
measurement of the cross-sectional area of the internal mammary
vessels. In this patient no malignancy was found. a Coronal view,
determining the Schwabegger classification. The left internal mamma-
ry artery and vein are visible. Medial the internal mammary artery
(IMA) and lateral the internal mammary vein (IMV). This anatomy is
comparable with Schwabegger’s type 4. b Sagittal view, marking the
manubrium. This marker appears automatically in the coronal and
transverse slices. c Transverse slice; using the marker the second
intercostal space is recognised and the cross-sectional area of the
internal mammary vessels (left and right arrows) can be measured
Table 2 Type of malignant lesion
Type of lesions n %
Ductal carcinoma in situ 4 9
Invasive ductal carcinoma 29 66
Lobular carcinoma in situ 1 2
Invasive lobular carcinoma 6 14
Other malignancy 4 9
Total 44 100
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When taking a cutoff point of 3.0-cm tumour diameter,
the mean difference of the cross-sectional area in the second
ICS for reader 1 was 1.43 mm2 in the group with tumours ≤
3.0 cm compared to 1.89 mm2 in the tumours bigger >
3.0 cm. This difference was not significant.
The sensitivity was 56.4 % (95 % CI 39–72 %) and
specificity 85.1 % (95 % CI 75–91 %) after calculating the
difference between the cross-sectional area of the left and right
IMA in the second ICS on a patient basis and a cutoff point of
1.00 mm2 (i.e. a difference < 1.00 mm2 between left and right,
no malignancy; when ≥ 1.00 mm2, malignant). Calculated
positive and negative predictive values were 62 % (95 % CI
45–78 %) and 81.3 % (95 % CI 71–88 %), respectively.
Discussion and further perspectives
This study showed that in healthy persons no significant
difference existed between the cross-sectional area of the
left and right IMA and IMV on MRI. In the presence of
malignancy this study showed a significant enlargement in
the cross-sectional area of the IMA and IMV on the malig-
nant side. With this knowledge bilateral comparison of the
internal mammary vessels evaluated in the second and third
ICS might be used as a predictor for the presence or absence
of malignancy. Based on these results it seems most appro-
priate to focus on the IMA. The IMA showed the biggest
enlargement of the cross-sectional area compared to the
IMV. As the preferred location for the measurement of the
cross-sectional area of the IMA the second ICS should be
considered. The enlargement of the IMA is more explicit in
the second ICS compared to the third ICS.
Increased breast vascularity can be explained by an in-
creased demand for blood flow, providing nutrients for
tumour growth [16]. In 2010 Carbognin et al. reported
features of inflammatory breast cancer on MRI. They
reported a hypertrophic IMA in 21 % of the patients [17].
In healthy persons the breast is mainly perfused by the IMA
Table 3 Control group
Control group Observed mean cross-sectional
area (mm2) left side
Observed mean cross-sectional
area (mm2) right side
Adjusted difference (mm2) P
Surface artery ICS 2 Reader 1 4.26 (1.99−12.41) 4.36 (2.08−11.06) 0.12 0.298
Reader 2 4.32 (1.02−7.93) 4.54 (2.15−8.31) 0.21 0.058
Surface vein ICS 2 Reader 1 3.35 (1.88−6.74) 3.51 (1.97−8.01) 0.19 0.098
Reader 2 3.42 (1.27−9.63) 3.69 (1.78−6.14) 0.23 0.052
Surface artery ICS 3 Reader 1 3.66 (1.88−7.22) 3.78 (1.93−8.88) 0.11 0.340
Reader 2 3.51 (1.97−8.14) 3.67 (1.53−6.86) 0.15 0.132
Surface vein ICS 3 Reader 1 2.92 (1.48−7.73) 3.13 (1.57−6.88) 0.20 0.074
Reader 2 2.73 (1.21−6.21) 2.93 (1.22−5.91) 0.21 0.094
In the third column the observed means are reported with the minimum and maximum for the left side. In the fourth column the same results are
reported for the right side. In the fifth column the adjusted differences between left and right side vessels are reported according to the linear mixed
model analysis. ICS Intercostal space
Table 4 Malignancy group
Malignancy group Observed mean cross-sectional
area (mm2) healthy side
Observed mean cross-sectional
area (mm2) lesion side
Adjusted difference (mm2) P
Surface artery ICS 2 Reader 1 4.63 (2.01−13.22) 5.94 (2.06−13.53) 1.37 0.000
Reader 2 4.46 (2.19−7.75) 5.24 (2.39−10.29) 0.81 0.003
Surface vein ICS 2 Reader 1 3.52 (0.26−7.51) 4.42 (1.95−13.81) 0.90 0.005
Reader 2 3.44 (1.16−5.71) 3.99 (1.86−7.21) 0.55 0.008
Surface artery ICS 3 Reader 1 3.99 (2.14−10.07) 5.04 (1.92−12.59) 1.03 0.000
Reader 2 3.58 (1.93−6.75) 4.08 (2.05−6.34) 0.51 0.007
Surface vein ICS 3 Reader 1 3.21 (1.78−7.22) 3.92 (1.95−7.83) 0.71 0.002
Reader 2 2.70 (1.38−4.90) 3.35 (1.25−6.92) 0.66 0.000
In the third column the observed means are reported with the minimum and maximum for the side with no malignancy. In the fourth column the
same results are reported for the malignant side. Column 5 shows the result of linear mixed model analysis in terms of adjusted difference in mm2 .
ICS Intercostal space
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[11]. The anatomy can vary per side in one person; there-
fore, comparing the left and right cross-sectional area of the
IMA and IMV could be difficult. Another anatomical
difference lies in the possible bifurcation of the IMV.
This bifurcation occurs mostly below the third rib; using
measurements only above this rib solves this problem.
Different imaging modalities were used for imaging in-
creased vascularity, for example, laser Doppler perfusion
imaging [18], positron emission tomography [19], computed
tomography (CT) [20] and MRI [4–6, 8, 10, 21–23]. With
respect to MRI, most researchers use one of two methods to
assess changes in vascularity in the presence of malignancy.
Using the AVS sign, Dietzel et al. reported a sensitivity of
47 % and a specificity of 88 % [10]. Others compared the
vascularity of the whole breast on both sides with contrast-
enhanced MRI. The images were assessed according to the
number of vessels, the length and maximum transverse
diameter [8]. Only vessels larger than 3 cm in length or
larger than 2 mm in diameter were counted. All measure-
ments were summarised and added. A sensitivity of 88 %
and a specificity of 82 % were reported for this method by
Sardanelli et al. [8].
The two currently used methods to assess breast vascu-
larity have different shortcomings.
Using whole breast vascularity, every branching vessel has
to be considered for counting or not. This is a subjective and
time-consuming procedure. Further, whole-breast vascularity
assessment is not possible after mastectomy. In addition, it is
possible that the diameter of the vessels increases in size,
while the number of vessels stays equal [20, 24].
In contrast to the whole-breast vascularity method, assess-
ment of the AVS is possible after breast-conserving therapy
(BCT) and unilateral mastectomy [24]. However, every inter-
vention in a breast could cause an inflammation response
resulting in enlargement of the (local) vessels. This can influ-
ence the sensitivity and specificity of the AVS, as Dietzel et al.
already mentioned [10, 24]. They also mentioned the need to
investigate the intra- and interobserver variability of the “AVS
method”, since assessment of the AVS is very subjective [10].
With our method a couple of the above-mentioned short-
comings can be overcome. The method is not time consuming;
only two measurements of the IMA are needed. The single
measurement of the IMA on the left and right side takes only
1 min. Furthermore, the measurements in this study were
reproducible by two independent readers, indicating onlyminor
interobserver variation. However, measurement of the internal
mammary vessels has its shortcomings. First of all, it is not
possible in patients who have undergone a coronary artery
bypass graft. After unilateral mastectomy it is also not possible
to make a reliable left-right comparison of the internal mam-
mary vessels. It is unclear whether tissue sampling in the breast
influences the cross-sectional area of the internal mammary
vessels because of an inflammation reaction after sampling. In
this study, a case mix of patients with and without tissue
sampling before breast MRI was included. We assumed that
tissue sampling causes only local changes in vascularisation
and does not influence the cross-sectional area of the internal
mammary vessels. In one of the breast cancer patients, the MRI
showed a major vascular “crossover” (see Fig. 4). A clear
connection between the right and left internal mammary artery
is visible. In our opinion a left-right comparison was not
reliable in this case. This problem does not occur during as-
sessment of vascularisation with the whole-breast vascularity
and AVS techniques.
A limitation of this study was the fact that only the
internal mammary vessels were investigated, although the
breast is supplied by both the IMA and the lateral thoracic
artery (LTA). A study by Doughty et al. showed that the
IMA perfuses 67 % of the breast and 15 % of the lateral
thoracic artery [11]. However, Grubstein et al. showed that
the increased blood supply of the IMA or LTA was depen-
dent on tumour localisation: 87 % of the medial tumours
were supplied mainly by the branches of the IMA and 13 %
by the branches of the LTA. The lateral tumours were
mainly supplied by the IMA in 48 % and by the LTA in
35 %. In 17 % of the lateral tumours no dominant vessel
Fig. 3 An example of the internal mammary vessels in a patient with a
unifocal lesion in the right breast. Measurement of the right internal
mammary artery showed a cross-sectional area of 9.6 mm2 on the right
side and 6.3 mm2 on the left. Histopathology showed an invasive
ductal carcinoma, 3.5 cm, grade 2, triple negative
Fig. 4 Transverse view on contrast-enhanced subtraction image. A
clear case of a “crossover”. There is a connection between the left
breast and the right internal mammary artery
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could be determined [21]. These data suggest that measure-
ment of the IMA is not sufficient in some patients, and
measurements of the LTA are needed. However, it would
be very difficult to measure the LTA. Because of the anat-
omy of the LTA a standardised location for measurements is
not available so inter- and intraobserver variability will not
be as good compared to the measurements of the IMA.
Also, the visualisation of a tumour within the breast
could introduce bias in the measurement, i.e. overestima-
tion of the cross-sectional areas at the side of the breast
cancer. Ideally, measurements of the vessels should be
performed without visualisation of the breast itself. How-
ever, this is not possible within our viewing workstations.
It is well known that tumour identification on breast MRI
depends heavily on the enhancement of tissue. It is very
difficult to detect breast cancers on non-enhanced T2-
weighted images (only larger tumours can be identified).
Also, to introduce this type of bias, the tumour should be
located at exactly the level of the second intercostal space
to be detected while performing these measurements. We
think that these considerations limit the introduction of
bias in these measurements.
This study provides new insights into the possibility of using
left-right IMA cross-sectional area differences as a possible new
predictor for malignancy onMRI. Further research is needed on
this topic. A future study should prospectively confirm these
retrospective results in a larger cohort. Also the use of a dedi-
cated MR angiographic sequence can be considered to obtain
more sufficient MR quality images. In addition, we would
suggest evaluating the possible correlation between tumour
diameter and cross-sectional vessel enlargement or assessing
the differences between various types of breast cancer, i.e.
invasive versus in situ cancers. Due to the limited number of
malignant cases, wewere unable to perform an accurate analysis
with respect to this research question. In the end, this study
showed differences between both groups, which might aid in
improving the specificity of breast MRI. Although this is a
plausible assumption, we wish to emphasise that this is only
speculative and that this theory should be evaluated in a larger
prospective study, especially with the addition of this new
parameter to the common used BI-RADS lexicon parameters.
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